CHMP endorses Eli Lilly’s GLP-1 pill and three other new drugs
RegulatorypositiveorforglipronWegovy pillPositive
AI Analysis
Summary
The EMA's CHMP endorsed Eli Lilly's oral GLP-1 pill orforglipron, giving it EU regulatory backing as Lilly seeks to catch up with Novo's Wegovy pill. Three other new drugs also received CHMP endorsement.
Outcome Details
CHMP issued a positive opinion endorsing Eli Lilly's oral GLP-1 pill orforglipron for EU marketing, alongside three other new drugs.
Importance:8/10
Sentiment:
0.70
CHMPEMAGLP-1oral GLP-1obesityregulatoryEU approval
Related Companies
Read the original article
Published by Endpoints News on October 16, 2026 2:55 PM